Dr. Aikaterini Thanou is a rheumatologist in Oklahoma City,Oklahoma.
Female
1316088016
Description | # of Times Performed | # of Patients | Average Charge ($) |
---|---|---|---|
Aspiration and/or injection of large joint or joint capsule | 39.0 | 27.0 | 120.0 |
Insertion of needle into vein for collection of blood sample | 636.0 | 244.0 | 27.0 |
X-ray of hand, minimum of 3 views | 135.0 | 64.0 | 75.0 |
X-ray of knee, 1 or 2 views | 25.0 | 21.0 | 125.0 |
X-ray of foot, minimum of 3 views | 61.0 | 29.0 | 64.770491803 |
Blood test, comprehensive group of blood chemicals | 629.0 | 246.0 | 39.0 |
Vitamin D-3 level | 38.0 | 33.0 | 104.0 |
Blood test, thyroid stimulating hormone (TSH) | 22.0 | 20.0 | 59.0 |
Uric acid level, blood | 120.0 | 71.0 | 16.0 |
Complete blood cell count (red cells, white blood cell, platelets), automated test | 624.0 | 244.0 | 27.0 |
Red blood cell sedimentation rate, to detect inflammation | 617.0 | 245.0 | 9.0 |
Measurement C-reactive protein for detection of infection or inflammation | 616.0 | 245.0 | 18.0 |
Rheumatoid factor level | 15.0 | 15.0 | 29.0 |
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 62.0 | 53.0 | 62.0 |
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 14.0 | 13.0 | 200.0 |
Infusion of chemotherapy into a vein up to 1 hour | 31.0 | 17.0 | 430.0 |
New patient office or other outpatient visit, typically 45 minutes | 22.0 | 22.0 | 308.0 |
Established patient office or other outpatient visit, typically 15 minutes | 14.0 | 13.0 | 120.0 |
Established patient office or other outpatient, visit typically 25 minutes | 556.0 | 235.0 | 179.84604317 |
Established patient office or other outpatient, visit typically 40 minutes | 72.0 | 61.0 | 250.0 |
Injection, methylprednisolone acetate, 40 mg | 45.0 | 38.0 | 40.0 |
Injection, methylprednisolone acetate, 80 mg | 73.0 | 55.0 | 75.0 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 144.0 | 27.0 | 10.83 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.